Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.
Identifieur interne : 004F52 ( PubMed/Corpus ); précédent : 004F51; suivant : 004F53Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.
Auteurs : J D Stratigos ; I. Potouridou ; A C Katoulis ; E. Hatziolou ; E. Christofidou ; A. Stratigos ; A. Hatzakis ; N G StavrianeasSource :
- International journal of dermatology [ 0011-9059 ] ; 1997.
English descriptors
- KwdEn :
- Age Factors, Aged, Aged, 80 and over, Bone Neoplasms (epidemiology), Bone Neoplasms (secondary), Disease-Free Survival, Edema (epidemiology), Endemic Diseases, Female, Foot Diseases (epidemiology), Foot Diseases (pathology), Greece (epidemiology), Hand (pathology), Humans, Incidence, Lymphatic Metastasis, Lymphedema (epidemiology), Male, Middle Aged, Mononuclear Phagocyte System (pathology), Neoplasm Staging, Neoplasms, Second Primary (epidemiology), Prospective Studies, Sarcoma, Kaposi (epidemiology), Sarcoma, Kaposi (pathology), Sarcoma, Kaposi (secondary), Sarcoma, Kaposi (therapy), Sex Factors, Skin Neoplasms (epidemiology), Skin Neoplasms (pathology), Skin Neoplasms (therapy), Survival Rate.
- MESH :
- geographic , epidemiology : Greece.
- epidemiology : Bone Neoplasms, Edema, Foot Diseases, Lymphedema, Neoplasms, Second Primary, Sarcoma, Kaposi, Skin Neoplasms.
- pathology : Foot Diseases, Hand, Mononuclear Phagocyte System, Sarcoma, Kaposi, Skin Neoplasms.
- secondary : Bone Neoplasms, Sarcoma, Kaposi.
- therapy : Sarcoma, Kaposi, Skin Neoplasms.
- Age Factors, Aged, Aged, 80 and over, Disease-Free Survival, Endemic Diseases, Female, Humans, Incidence, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Prospective Studies, Sex Factors, Survival Rate.
Abstract
Classic Kaposi's sarcoma (CKS) is not uncommon in Greece with a reported incidence of 0.20 per 100,000 per year.
PubMed: 9372346
Links to Exploration step
pubmed:9372346Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.</title><author><name sortKey="Stratigos, J D" sort="Stratigos, J D" uniqKey="Stratigos J" first="J D" last="Stratigos">J D Stratigos</name><affiliation><nlm:affiliation>Department of Dermatology and Venereology, A. Sygros Hospital, Athens, Greece.</nlm:affiliation></affiliation></author><author><name sortKey="Potouridou, I" sort="Potouridou, I" uniqKey="Potouridou I" first="I" last="Potouridou">I. Potouridou</name></author><author><name sortKey="Katoulis, A C" sort="Katoulis, A C" uniqKey="Katoulis A" first="A C" last="Katoulis">A C Katoulis</name></author><author><name sortKey="Hatziolou, E" sort="Hatziolou, E" uniqKey="Hatziolou E" first="E" last="Hatziolou">E. Hatziolou</name></author><author><name sortKey="Christofidou, E" sort="Christofidou, E" uniqKey="Christofidou E" first="E" last="Christofidou">E. Christofidou</name></author><author><name sortKey="Stratigos, A" sort="Stratigos, A" uniqKey="Stratigos A" first="A" last="Stratigos">A. Stratigos</name></author><author><name sortKey="Hatzakis, A" sort="Hatzakis, A" uniqKey="Hatzakis A" first="A" last="Hatzakis">A. Hatzakis</name></author><author><name sortKey="Stavrianeas, N G" sort="Stavrianeas, N G" uniqKey="Stavrianeas N" first="N G" last="Stavrianeas">N G Stavrianeas</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1997">1997</date><idno type="RBID">pubmed:9372346</idno><idno type="pmid">9372346</idno><idno type="wicri:Area/PubMed/Corpus">004F52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004F52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.</title><author><name sortKey="Stratigos, J D" sort="Stratigos, J D" uniqKey="Stratigos J" first="J D" last="Stratigos">J D Stratigos</name><affiliation><nlm:affiliation>Department of Dermatology and Venereology, A. Sygros Hospital, Athens, Greece.</nlm:affiliation></affiliation></author><author><name sortKey="Potouridou, I" sort="Potouridou, I" uniqKey="Potouridou I" first="I" last="Potouridou">I. Potouridou</name></author><author><name sortKey="Katoulis, A C" sort="Katoulis, A C" uniqKey="Katoulis A" first="A C" last="Katoulis">A C Katoulis</name></author><author><name sortKey="Hatziolou, E" sort="Hatziolou, E" uniqKey="Hatziolou E" first="E" last="Hatziolou">E. Hatziolou</name></author><author><name sortKey="Christofidou, E" sort="Christofidou, E" uniqKey="Christofidou E" first="E" last="Christofidou">E. Christofidou</name></author><author><name sortKey="Stratigos, A" sort="Stratigos, A" uniqKey="Stratigos A" first="A" last="Stratigos">A. Stratigos</name></author><author><name sortKey="Hatzakis, A" sort="Hatzakis, A" uniqKey="Hatzakis A" first="A" last="Hatzakis">A. Hatzakis</name></author><author><name sortKey="Stavrianeas, N G" sort="Stavrianeas, N G" uniqKey="Stavrianeas N" first="N G" last="Stavrianeas">N G Stavrianeas</name></author></analytic><series><title level="j">International journal of dermatology</title><idno type="ISSN">0011-9059</idno><imprint><date when="1997" type="published">1997</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Bone Neoplasms (epidemiology)</term><term>Bone Neoplasms (secondary)</term><term>Disease-Free Survival</term><term>Edema (epidemiology)</term><term>Endemic Diseases</term><term>Female</term><term>Foot Diseases (epidemiology)</term><term>Foot Diseases (pathology)</term><term>Greece (epidemiology)</term><term>Hand (pathology)</term><term>Humans</term><term>Incidence</term><term>Lymphatic Metastasis</term><term>Lymphedema (epidemiology)</term><term>Male</term><term>Middle Aged</term><term>Mononuclear Phagocyte System (pathology)</term><term>Neoplasm Staging</term><term>Neoplasms, Second Primary (epidemiology)</term><term>Prospective Studies</term><term>Sarcoma, Kaposi (epidemiology)</term><term>Sarcoma, Kaposi (pathology)</term><term>Sarcoma, Kaposi (secondary)</term><term>Sarcoma, Kaposi (therapy)</term><term>Sex Factors</term><term>Skin Neoplasms (epidemiology)</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (therapy)</term><term>Survival Rate</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Greece</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bone Neoplasms</term><term>Edema</term><term>Foot Diseases</term><term>Lymphedema</term><term>Neoplasms, Second Primary</term><term>Sarcoma, Kaposi</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Foot Diseases</term><term>Hand</term><term>Mononuclear Phagocyte System</term><term>Sarcoma, Kaposi</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Bone Neoplasms</term><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Sarcoma, Kaposi</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Aged, 80 and over</term><term>Disease-Free Survival</term><term>Endemic Diseases</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Lymphatic Metastasis</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prospective Studies</term><term>Sex Factors</term><term>Survival Rate</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Classic Kaposi's sarcoma (CKS) is not uncommon in Greece with a reported incidence of 0.20 per 100,000 per year.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9372346</PMID><DateCreated><Year>1997</Year><Month>12</Month><Day>23</Day></DateCreated><DateCompleted><Year>1997</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0011-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>1997</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of dermatology</Title><ISOAbbreviation>Int. J. Dermatol.</ISOAbbreviation></Journal><ArticleTitle>Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.</ArticleTitle><Pagination><MedlinePgn>735-40</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Classic Kaposi's sarcoma (CKS) is not uncommon in Greece with a reported incidence of 0.20 per 100,000 per year.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Epidemiological, clinical and histological features of all CKS cases, diagnosed in 'A. Sygros' hospital, Athens, Greece during the years 1989-1994, have been recorded and studied prospectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the five-year period studied, 66 CKS patients have been diagnosed in our hospital. Incidence among dermatologic patients was 2.11 per 10,000 patients examined, representing 1.35% of total skin malignancies. Patients' age at diagnosis ranged from 53 to 94 years (mean 72 +/- 8.8). The male to female ratio was 2.47:1. A high proportion of the patients were born in Peloponnesos (42.42%) and were residing in Athens (51.51%) or in Peloponnesos (24.24%). Nodules and/or plaques were the most frequent type of lesion, most commonly located on the feet (43.93%) or the hands (28.78%). Accompanying edema was seen in 51.51% of the patients. There were 16 stage I patients (24.24%), 40 stage II (60.60%), 0 stage III and 10 stage IV (15.15%). Involvement of visceral organs was detected in seven patients (10.60%), while 10 had lymph node involvement (15.15%) and three, involvement of the underlying bones (4.54%). Second primary malignancy was diagnosed in 6 cases (9.09%), most often of the reticuloendothelial system (83.33%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CKS in Greece exhibits some special characteristics, including older age of onset; lower male to female ratio; endemic clustering; disseminated skin disease at diagnosis, often accompanied by lymphedema; not unusual visceral or lymph node involvement and association with second malignancies. We suggest that CKS in Greece possibly represents a distinct endemic subtype of CKS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stratigos</LastName><ForeName>J D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Dermatology and Venereology, A. Sygros Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potouridou</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Katoulis</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Hatziolou</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Christofidou</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Stratigos</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hatzakis</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Stavrianeas</LastName><ForeName>N G</ForeName><Initials>NG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Dermatol</MedlineTA><NlmUniqueID>0243704</NlmUniqueID><ISSNLinking>0011-9059</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004487" MajorTopicYN="N">Edema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005534" MajorTopicYN="N">Foot Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006115" MajorTopicYN="N" Type="Geographic">Greece</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006225" MajorTopicYN="N">Hand</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012157" MajorTopicYN="N">Mononuclear Phagocyte System</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016609" MajorTopicYN="N">Neoplasms, Second Primary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>12</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>12</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9372346</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004F52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:9372346
|texte= Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:9372346" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |